MyAverix Finance
F · Healthcare
MEDEXUS PHARMACEUTIC. (P731)
Drug Manufacturers - Specialty & Generic
MEDEXUS PHARMACEUTIC. (P731) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $62.62M, P/E ratio is 18.00, net margin is -0.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for P731
MEDEXUS PHARMACEUTIC. (P731) — FAQ
What is MEDEXUS PHARMACEUTIC.'s market cap?
MEDEXUS PHARMACEUTIC. (P731) has a reported market cap of $62.62M (data as of 2026-03-30).
What is P731's P/E ratio?
The price-to-earnings (P/E) ratio for MEDEXUS PHARMACEUTIC. (P731) is 18.00 (data as of 2026-03-30).
Does MEDEXUS PHARMACEUTIC. pay a dividend?
Dividend yield is not available in the current snapshot for MEDEXUS PHARMACEUTIC. (P731). Check the MyAverix Finance app for the latest dividend data.
What sector is MEDEXUS PHARMACEUTIC. in?
MEDEXUS PHARMACEUTIC. (P731) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is P731 listed on?
P731 is listed on F.
What is MEDEXUS PHARMACEUTIC.'s net margin?
MEDEXUS PHARMACEUTIC. (P731) reports a net margin of -0.3% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.